Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Late Stage Parkinson's Disease”

Showing 9 of 0 results

Very early researchLooking for participantsNCT07100171
What this trial is testing

Evaluation of GM101 Injection in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Genemagic Biosciences Co., Ltd 10
Large-scale testing (Phase 3)Study completedNCT01187966
What this trial is testing

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 669
Testing effectiveness (Phase 2)Looking for participantsNCT06167681
What this trial is testing

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease
iRegene Therapeutics Co., Ltd. 40
Post-approval studies (Phase 4)Ended earlyNCT03968744
What this trial is testing

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease (at Later Stage)
Alain Kaelin 11
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Testing effectiveness (Phase 2)Ended earlyNCT00903838
What this trial is testing

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

Who this might be right for
Advanced Stage Parkinson's Disease
Abbott Products 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07028632
What this trial is testing

The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00145171
What this trial is testing

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 56
Testing effectiveness (Phase 2)Study completedNCT01631812
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 130

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation